DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/9shgp3/international_stro) has announced the addition of GlobalData's new report "International Stroke Conference 2012 - Post-Conference Review and Analysis" to their offering.
International Stroke Conference 2012 - Post-Conference Review and Analysis.
The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques. The annual meeting of the International Stroke Conference 2012 was held in New Orleans, the US, on February 1-3, 2012. This two and a half day conference provides a forum in which to present recent scientific work related to cerebrovascular disease. More than 1,000 abstract presentations, lectures and debates will be featured. Some of the topics covered in the conference include clinical categories such as diagnosis, acute non-endovascular treatment, in-hospital treatment, rehabilitation and recovery, pediatric stroke, prevention, community/risk factors, nursing, emergency medicine, outcomes, vascular biology, and vascular cognitive impairment. This report aims to cover some of the scientific presentations and articles released during the conference.
Key Topics Covered:
1 List of Tables
2 International Stroke Conference 2012 - Pre-conference Highlights
2.1 Full Dose IV-tPA Followed by IA Therapy for Acute Ischemic Stroke Does not Increase Morbidity or Mortality
2.2 Treatment of Acute Stroke in Patients on Dabigatran: A Survey of US Stroke Specialists
2.3 Efficacy and Safety of Rivaroxaban Compared with Warfarin among Elderly Patients with Nonvalvular Atrial Fibrillation in the ROCKET-AF Trial
View post:
Research and Markets: International Stroke Conference 2012 - Post-Conference Review and Analysis